To verify the correlation between SYNJ2 and tumors, Ben-Chetrit et al. used an online informatics tool to show that high SYNJ2 transcript levels indicated a shorter lifespan for patients with lung cancer. This evidence concerns the gene SYNJ2 and lung carcinoma.